In cluster randomized controlled trials (CRCT) with a finite populations, the exact design-based variance of the Horvitz-Thompson (HT) estimator for the average treatment effect (ATE) depends on the joint distribution of unobserved cluster-aggregated potential outcomes and is therefore not point-identifiable. We study a common two-stage sampling design-random sampling of clusters followed by sampling units within sampled clusters-with treatment assigned at the cluster level. First, we derive the exact (infeasible) design-based variance of the HT ATE estimator that accounts jointly for cluster- and unit-level sampling as well as random assignment. Second, extending Aronow et al (2014), we provide a sharp, attanable upper bound on that variance and propose a consistent estimator of the bound using only observed outcomes and known sampling/assignment probabilities. In simulations and an empirical application, confidence intervals based on our bound are valid and typically narrower than those based on cluster standard errors.
The Exact Variance of the Average Treatment Effect Estimator in Cluster Randomized Controlled Trials
Published 2025 in Unknown venue
ABSTRACT
PUBLICATION RECORD
- Publication year
2025
- Venue
Unknown venue
- Publication date
2025-11-08
- Fields of study
Economics
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-19 of 19 references · Page 1 of 1
CITED BY
- No citing papers are available for this paper.
Showing 0-0 of 0 citing papers · Page 1 of 1